Abstract
Children suffering from Acute Lymphoblastic Leukaemia (ALL) treated with asparaginase and corticosteroids are at risk of developing severe lipid abnormalities. The authors report the case of a 10-year-old male with extremely high plasma triglyceride concentrations (4,000 mg/dl) during the induction phase of ALL associated with mild pancreatitis. Hypertriglyceridemia was successfully managed with plasmapheresis with a decrease in triglyceride levels to 590 mg/dl. Apheresis appears to be safe and effective in reducing hypertriglyceridemia and preventing related complications.
(c) 2007 Wiley-Liss, Inc.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Asparaginase / administration & dosage
-
Asparaginase / adverse effects
-
Child
-
Combined Modality Therapy
-
Humans
-
Hypertriglyceridemia / blood
-
Hypertriglyceridemia / etiology
-
Hypertriglyceridemia / therapy*
-
Leukapheresis
-
Male
-
Plasmapheresis*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / blood*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
-
Remission Induction
-
Triglycerides / blood
Substances
-
Triglycerides
-
Asparaginase